Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,382 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06635837Recruiting
MRI for ovarian masses during pregnancy
This study looks at whether MRI can help doctors better understand ovarian masses found during pregnancy. It aims to improve diagnosis and care for you and your baby.
RomeAges 18 years+ - NCT06636513Recruiting
Testing SMT04 for irritable bowel syndrome
This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.
Singapore, SingaporeAges 21–55 - NCT06636474Recruiting
Supported housing for people with mental disorders
This study looks at a supported housing program to help people with mental health conditions live more independently. It aims to see if this program improves social inclusion and quality of life.
ParisAges 18–60 - NCT06636526Recruiting
Testing a new prostate cancer blood test in diverse groups
This study tests a new blood test (PRODICT®) to see how well it works for finding prostate cancer in men from different ethnic backgrounds. It aims to make sure the test is accurate and fair for everyone.
Sutton, SurreyAges 40–55 - NCT06637267Recruiting
Testing a new blood test to improve prostate cancer risk assessment
This trial is testing a new blood test (Proclarix) to see if it can better predict prostate cancer risk in men who are already scheduled for an MRI and prostate biopsy. The goal is to improve how doctors decide who needs a biopsy.
Aarau, Canton of AargauAges 45–80 - NCT06641011Recruiting
Sealing molars with enamel spots: rinsing vs blotting
This study tests whether rinsing off or blotting dry a special silver fluoride liquid before placing a tooth sealant helps the sealant last longer on molars affected by a common condition called molar-incisor hypomineralization. The goal is to find the best way to protect these teeth from cavities.
AnkaraAges 6–14 - NCT06641895RecruitingEarly Phase 1
Testing BBM-D101 gene therapy for Duchenne muscular dystrophy
This early-phase study tests a new gene therapy called BBM-D101 for boys with Duchenne muscular dystrophy (DMD). The goal is to see if it is safe and helps improve muscle function in young boys.
Shanghai, Shanghai MunicipalityAges 4–8 - NCT06641999Recruiting
Tinnitus implant study for adults with chronic tinnitus and hearing loss
This trial tests if a special implant can reduce tinnitus loudness in adults who have had chronic tinnitus for at least 6 months and have some hearing loss. You may qualify if your tinnitus is severe and not helped by standard treatments like hearing aids or therapy.
Edegem, BelgiumAges 18 years+ - NCT06642623RecruitingPhase 4
Study on heart and kidney health in type 2 diabetes
This trial tests enavogliflozin (a newer SGLT2 inhibitor) compared to older drugs (dapagliflozin or empagliflozin) to see how well it protects the heart and kidneys in people with type 2 diabetes.
SeoulAges 19 years+ - NCT06642831Recruiting
PCOS biomarker study for young women
This study looks for biological markers of polycystic ovary syndrome (PCOS) in young women. If you are between 15 and 25 and have not used hormonal birth control recently, you may be able to help researchers find better ways to diagnose PCOS.
ErlangenAges 15–25 - NCT06643000Recruiting
High-dose furmonertinib combo for EGFR lung cancer with brain lining spread
This trial tests a strong dose of furmonertinib (a targeted pill) combined with two other drugs, bevacizumab and pemetrexed, for people with EGFR-mutated non-small cell lung cancer that has spread to the lining of the brain or spinal cord. It aims to see if this combination can better control the cancer and improve symptoms.
Zhengzhou, HenanAges 18 years+ - NCT06643130RecruitingPhase 3
Testing a combo treatment for high blood pressure and cholesterol
This study tests whether adding two medications together helps people who have both high blood pressure and high cholesterol. It aims to see if the combination works better and is safe.
SeoulAges 19 years+ - NCT06643273Recruiting
Glove to measure touch feeling after stroke
This study tests a special glove that helps measure how well you can feel touch after a stroke. It's for people who had a single stroke within the last 6 months and have some thinking and memory ability.
Florence, ItalyAges 18–85 - NCT06643286Recruiting
Melanoma survivorship care plan app study
This trial tests a mobile app that provides a personalized survivorship care plan for people recently diagnosed with early-stage melanoma. It aims to help patients manage their follow-up care and improve quality of life.
Dordrecht, South HollandAges 18 years+ - NCT06643507RecruitingPhase 2/Phase 3
Testing a new gum repair technique for receding gums
This trial compares two ways to fix receding gums (a condition where your gums pull away from your teeth). It tests a newer technique using your own blood products versus a traditional graft to see which works better for moderate gum recession.
CairoAges 18–60 - NCT06643767Recruiting
Testing a new breast exam device during mammogram
This study tests a new device called Bexa that examines the breast to see if it works well along with a standard mammogram. It may help find breast concerns more easily.
Abilene, TexasAges 30–75 - NCT06643793RecruitingPhase 2
Irinotecan liposome combo for advanced colorectal cancer
This trial tests a new form of the chemotherapy drug irinotecan (called irinotecan liposome) combined with two other chemo drugs and a targeted therapy (bevacizumab) for people with advanced colorectal cancer that has already been treated with oxaliplatin. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
Nanjing, JiangsuAges 18–75 - NCT06643819RecruitingPhase 3
Testing a new blood pressure drug
This trial tests a new combination blood pressure medicine called CKD-202A. It is for adults with high blood pressure who have not had other treatments or conditions that could affect the results.
WŏnjuAges 19 years+ - NCT06646471RecruitingPhase 4
Study of cancer drugs for older adults with lung cancer
This trial tests approved cancer drugs in people aged 70 and older with non-small-cell lung cancer who haven't had systemic treatment before. The goal is to see how well these drugs work in this older population.
Aix-en-ProvenceAges 70 years+ - NCT06646484Recruiting
Using a device to check hydration after brain bleeding
This study tests a new way to monitor your body's water and sodium levels using a simple, painless device (impedancemetry) after a subarachnoid hemorrhage. It may help doctors better manage your hydration and prevent complications during your ICU stay.
Lyon, FranceAges 18 years+ - NCT06647043Recruiting
Can synbiotics help irritable bowel syndrome?
This study tests whether a synbiotic (a mix of good bacteria and fiber) can improve symptoms of irritable bowel syndrome (IBS), especially for people with diarrhea-predominant or mixed type IBS, or functional diarrhea.
Kubang Kerian, KelantanAges 18–70 - NCT06647069RecruitingPhase 1
Testing a new drug for lupus and rheumatoid arthritis
This study tests an investigational drug called SAR448501/DR-0201 in people with active lupus or rheumatoid arthritis who have not responded well to standard treatments. The goal is to see if the drug is safe and helps control disease activity.
Brisbane, QueenslandAges 18–75 - NCT06647485Recruiting
Pulsed Field Ablation for Paroxysmal Atrial Fibrillation
This trial studies a new procedure called pulsed field ablation to treat brief episodes of atrial fibrillation (AFib). The goal is to see if it can help reset the heart's natural electrical system and reduce symptoms.
Aalst, BelgiumAges 18–70 - NCT06647745RecruitingPhase 3
Study for type 2 diabetes and high blood pressure
This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.
SeoulAges 19 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,382 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.